Gibson, Dunn & Crutcher, Australian firm Corrs Chambers Westgarth and King & Wood Mallesons are playing lead roles on a $750 million deal that will see a consortium led by Goldman Sachs Private Equity Group and Queensland Investment Corp. acquire a majority stake in Brisbane-based health care company Icon Cancer Care Group.
In the deal announced in late May, the U.S. investment bank and the Queensland state-backed asset manager teamed up with Chinese buyout firm Pagoda Investment to buy a majority stake in Icon from Sydney-based investor Quadrant Private Equity. Details of the deal were not disclosed but several media outlets, including Bloomberg and The Australian, reported its value at A$1 billion, or $750 million.
